Pathway Financial Advisers’s Mirum Pharmaceuticals MIRM Stock Holding History

Pathway Financial Advisers’s Portfolio MIRM Stock Details MIRM Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$6.38K	Buy
2025 Q1	–	Sell
2024 Q4	$3.6K	Hold
2024 Q3	$3.39K	Hold
2024 Q2	$2.98K	Buy